Watson launches Gelnique for overactive bladder
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals has launched Gelnique (oxybutynin chloride) gel 10%, the first topical gel for patients with overactive bladder (OAB), in the US.